SB 1212: health insurance; reimbursement rates; vaccines
SB 1212 status: Vetoed — Vetoed by Governor (updated Jun 19, 2026).
What this bill does
Overall score
Bill summary
Officialhealth insurance; reimbursement rates; vaccines. Currently in Senate.
Key analysis
Impact analysis
Environment
Benefits
- No direct impact identified
Risks
- No direct impact identified
Economy
Benefits
- Prevents potential financial penalties for providers treating unvaccinated patients
Risks
- Could disrupt value-based reimbursement models
- May increase administrative compliance costs for insurers
Society
Benefits
- Protects patients from provider bias based on medical decisions
- Supports patient bodily autonomy
Risks
- May limit financial incentives for providers to promote vaccination
- Could complicate public health outcomes associated with immunization
How trustworthy & consequential it is
Source
LegiScan
Confidence
highhigh
Analysis status
LegiScan full bill text
Could unintentionally discourage providers from participating in quality-improvement programs linked to vaccination benchmarks
Full impact on specific value-based care contracts is theoretical
Where it stands
Introduced
CompleteCommittee
CompleteFloor
CompleteGovernor
CompleteEnacted
UpcomingHow it affects your district
Set your location
Add your district to see how this bill may affect your community and who to contact.
Take action
Contact your representatives
Let them know how you feel about this bill.
Share your view
Join the discussion and see what others are saying.
Track this bill
Stay updated on progress and changes.